APA Citation

Entezari, M., Ramezani, A., & Yaseri, M. (2012). Intravitreal Bevacizumab for Treatment of Refractory Central Serous Choroidoretinopathy. The Korean Ophthalmological Society.

Chicago Style Citation

Entezari, Morteza, Alireza Ramezani, and Mehdi Yaseri. Intravitreal Bevacizumab for Treatment of Refractory Central Serous Choroidoretinopathy. The Korean Ophthalmological Society, 2012.

MLA Citation

Entezari, Morteza, Alireza Ramezani, and Mehdi Yaseri. Intravitreal Bevacizumab for Treatment of Refractory Central Serous Choroidoretinopathy. The Korean Ophthalmological Society, 2012.

Warning: These citations may not always be 100% accurate.